News

Aaron Ferguson’s diagnosis completely changed his life’s path. Since then, he has helped others overcome their addictions and get hepatitis C (HCV) treatment. In his home state of Texas, a new health initiative is looking to get more people into the continuum of care for this curable virus.

Increased sales of these antibiotics during the COVID-19 pandemic raise concerns about the growing threat of antimicrobial resistance.

ViiV Healthcare is working with 3 companies to manufacture generic versions of cabotegravir long-acting (LA).

This study examined the impact of COVID-19 vaccination and infection on the risk of cardiac and all-cause mortality in young people aged 12-29 years.

The CDC’s recent warning of the rising incidence rates of the fungal infection is cause for concern, but understanding which patients and settings are at a higher risk is equally as important. The lead author in the CDC’s recent C auris study offers some insights for both medical institutions and the general public.

Because trust in science predicts willingness to get a COVID-19 vaccine, the results of this study have significant public health consequences.

The oral RNA destabilizer, AB-161, developed by Arbutus Biopharma, started dosing its first participant for the small trial.

Early treatment with nirmatrelvir-ritonavir (Paxlovid) was associated with the greatest clinical benefit in reducing COVID-19 hospitalization and death.

The virus can maintain a reservoir in these white blood cells even in those who have been virally suppressed for years.

When given within 5 days of COVID-19 symptoms, Paxlovid appeared to reduce risk for developing Post-COVID-19 Conditions (PCC).

A new study found negative expectations prior to COVID-19 vaccination were associated with more systemic adverse events in individuals receiving their second dose of a COVID-19 vaccine.

A midsized study demonstrated no therapeutic benefit to patients with mild-to-moderate COVID-19 taking this class of anthelmintics.

"Antibiotics can safely be withheld in most patients with viral respiratory infections,” these study authors wrote.

An intensive care physician offers some insights looking at fluoroquinolone-associated tendinopathy and using this social media platform to provide education and an open discussion around it.

Risk factors for VTE among COVID-19 patients included age greater than 55 years, male gender, a history of thrombophilia, and obesity.

Data from the US Veterans Affairs found a wide range of gastrointestinal disorders were more likely among patients who had been infected with SARS-CoV-2 within a year after the acute phase of the disease.

Using a novel approach to identify E coli, investigators find approximately 8% of the bacterium’s isolates were foodborne zoonotic strains.

This week's hottest topics included the risks of proton pump inhibitors, rare tickborne disease, HIV vaccination, COVID-19 immunity from a common cold, and hydrocortisone for pneumonia.

March 24 is World Tuberculosis Day. Here’s a brief history of the second deadliest infectious disease, and how it affects the world today.

A new study reveals how US states fared, and some of the underlying reasons why the pandemic has played out in vastly different ways.

Using a pregnant rabbit model, investigators found a robust antigen-specific antibody response in pregnant rabbits against HIV and Zika virus.

On this day of commemoration, The Bill & Melinda Gates Medical Research Institute has multiple TB therapies and a prophylactic vaccine in development, and its Chief Medical Officer Michael W. Dunne, MD, remains optimistic long-term about the state of clinical care, especially in areas of dire need such as low-and-middle-income countries.

A new study shows vaccination decreased the chances of developing the debilitating condition by nearly half.

A food for thought as an ambulatory antibiotic stewardship initiative.

The patient, referred to as the “New York patient,” was treated with stem cells from cord blood, and has remained HIV-free in her blood since her transplant in 2017.

With yesterday’s FDA decision, Cidara’s injectable antifungal rezafungin become the first new drug approved to treat candidemia and invasive candidiasis in over a decade.

Climate change is causing ticks and mosquitos to migrate further north and with them comes disease, previously not seen in these geographic areas. One company is using data to model predictive vector habitats to help organizations and governments identify patterns and help prevent the spread of such diseases.

Candida auris fungal infections increased 95% in 2021, and drug-resistant cases are continuing to spread across the US.